Skip to main content

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model





) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole was unchanged today. By the end of trading, WellPoint rose $1.30 (2.3%) to $58.57 on light volume. Throughout the day, 2.8 million shares of WellPoint exchanged hands as compared to its average daily volume of four million shares. The stock ranged in a price between $57-$58.57 after having opened the day at $57.25 as compared to the previous trading day's close of $57.27. Other companies within the Health Care sector that increased today were:

Sunrise Senior Living



), up 59.7%,




), up 15%,

Brookdale Senior Living



), up 10.9%, and

Assisted Living Concepts



), up 9.6%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

WellPoint, Inc., through its subsidiaries, operates as a health benefits company in the United States. The company offers various network-based managed care plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $18.68 billion and is part of the

health services

industry. The company has a P/E ratio of 7.8, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 13.6% year to date as of the close of trading on Tuesday. Currently there are eight analysts that rate WellPoint a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates WellPoint as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front,

Peregrine Pharmaceuticals



), down 16.9%,

Escalon Medical Corporation



), down 9.3%,

BioMimetic Therapeutics



), down 9.1%, and

Idera Pharmaceuticals



), down 7.9%, were all laggards within the health care sector with

C.R. Bard



) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care